Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Effects of major adipokines and the -420 C > G resistin gene polymorphism on the long-term outcome of patients with acute ischemic stroke..
Int J Neurosci. 129(10), 978-985.
(2019). Adipose tissue, obesity and non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 92-108.
(2017).
(2017). The role of adipokines in ischemic stroke risk stratification..
Int J Stroke. 11(4), 389-98.
(2016). Irisin in patients with nonalcoholic fatty liver disease..
Metabolism. 63(2), 207-17.
(2014). Adipocytokines levels at delivery, functional variation of TFAP2β, and maternal and neonatal anthropometric parameters..
Obesity (Silver Spring). 21(10), 2130-7.
(2013). Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children..
Regul Pept. 183, 69-73.
(2013). Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms..
Obes Rev. 14(12), 1006-22.
(2013). Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss..
Obes Facts. 5(4), 495-504.
(2012). Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children..
Metabolism. 61(4), 562-8.
(2012). The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass..
Clin Endocrinol (Oxf). 77(6), 816-22.
(2012). Adipokines and stroke: a review of the literature..
Maturitas. 70(4), 322-7.
(2011). Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study..
Int J Clin Pract. 65(6), 679-83.
(2011). Insulin resistance in relation to melanoma risk..
Melanoma Res. 21(6), 541-6.
(2011). Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin..
Med Hypotheses. 74(6), 1089-90.
(2010). Should adipokines be considered in the choice of the treatment of obesity-related health problems?.
Curr Drug Targets. 11(1), 122-35.
(2010). Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis..
J Clin Endocrinol Metab. 94(8), 2692-701.
(2009). Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines..
Curr Mol Med. 9(3), 299-314.
(2009).